(UroToday.com) In this presentation, Dr. Pilar Laguna summarized results from the TRISST and SEMS trials, both of which aim to reduce risks associated with treatment and surveillance for stage 1 or early metastatic seminoma.
(UroToday.com) In this presentation, Dr. Pilar Laguna summarized results from the TRISST and SEMS trials, both of which aim to reduce risks associated with treatment and surveillance for stage 1 or early metastatic seminoma.